drugset / Trial / NCT00002524
Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with AIDS-related lymphoma.
Timeline
- Start
- 1993-06
- Primary completion
- 2005-10
- Completion
- 2005-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bleomycin | Unknown | — | — |
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | Cyclophosphamide | Other / unclassified | — | — |
| Subject | Cytarabine | Small molecule | — | — |
| Subject | Doxorubicin | Other / unclassified | — | — |
| Subject | Etoposide | Small molecule | — | — |
| Subject | Ifosfamide | Small molecule | — | — |
| Subject | Methotrexate | Small molecule | — | — |
| Subject | Methylprednisolone | Other / unclassified | — | — |
| Subject | Prednisone | Other / unclassified | — | — |
| Subject | Vincristine | Small molecule | — | — |
| Subject | fluorouracil | Small molecule | — | — |
| Background | Leucovorin | Small molecule | — | — |
| Background | Pentamidine | Unknown | — | — |
| Background | Zidovudine | Small molecule | — | — |
| Background | filgrastim | Protein / enzyme biologic | — | — |
| Background | trimethoprim-sulfamethoxazole | Unknown | — | — |